Bupropion Hydrochloride
- Product NDC
- 64679-103
- 11-digit product format
- 646790103
- Labeler code
- 64679
- Product ID
- 64679-103_f0f5ceaa-d325-5948-e053-2a95a90a94e2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bupropion Hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Wockhardt USA LLC.
- Application
- ANDA202189
- Marketing category
- ANDA
- Marketing start
- 2022-01-28
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64679-103-01 | 64679010301 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64679-103-01) | 2022-01-28 | 0000-00-00 | No | No | Current |
| 64679-103-02 | 64679010302 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64679-103-02) | 2022-01-28 | 0000-00-00 | No | No | Current |
| 64679-103-05 | 64679010305 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (64679-103-05) | 2022-01-28 | 0000-00-00 | No | No | Current |